연구동향 분석

악성 흑색종 환자에서 중합효소연쇄반응 기반의 BRAF 유전자 돌연변이 검사의 진단적 유효성: 체계적 문헌 고찰

신해원 고려진 이 민 방희영 권계철 박종우 구선회 2014년

논문상세정보
인용/피인용

' 악성 흑색종 환자에서 중합효소연쇄반응 기반의 BRAF 유전자 돌연변이 검사의 진단적 유효성: 체계적 문헌 고찰' 의 참고문헌

  • 유방암에서 HER2 유전자 검사를 위한 자동화 은제자리부합법 검사의 유용성: 형광제자리부합법과 면역조직화학염색과의 비교
    배영경 Journal of Pathology and Translational Medicine 44 1 28-34 [2010]
  • 갑상선 유두암에서의 BRAF 변이와 예후인자와의 관계
    나소영 Endocrinology and Metabolism 20 3 224-229 [2005]
  • The nature of melanoma. A critical review
    McGovern VJ J Cutan Pathol 9 61-81 [1982]
  • The association between MC1R genotype and BRAF mutation status in cutaneous melanomas : findings from an Australian population
    Hacker E J Invest Dermatol 130 241-248 [2010]
  • Multisite analytic performance studies of a Real-Time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed paraffin embedded tissue specimens of malignant melanoma
    Anderson S Arch Pathol Lab Med 136 1385-1391 [2012]
  • Laboratory Medicine
  • Inhibition of mutated, activated BRAF in metastatic melanoma
    Flaherty KT New Engl J Med 363 809-819 [2010]
  • In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation
    Venesio T Mod Pathol 21 716-726 [2008]
  • High frequency of BRAF mutations in nevi
    Pollock PM Nat Genet 33 19-20 [2003]
  • Hand surgery
    Cunnon B 776-777 [1982]
  • Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas
    김대철 Journal of Pathology and Translational Medicine 46 3 246-252 [2012]
  • Distinct clinical and pathological features are associated with the BRAFT1799A(V600E)mutation in primary melanoma
    Liu W J Invest Dermatol 127 900-905 [2007]
  • Detecting BRAF mutations in formalin-fixed melanoma : experiences with twostate-of-the-art techniques
    Schoenewolf NL Case Rep Oncol 5 280-289 [2012]
  • Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: preapproval validation study of the companion diagnostic test for vemurafenib
    Lopez-Rios F PLoS ONE 8 e53733- [2013]
  • Clinical experiences in malignant melanoma
    Kim JO J Korean Surg Soc 53 905-910 [1997]
  • Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma
    Lazar V Mod Pathol 22 1367-1378 [2009]
  • BRIM-3 Study Group. Improved survival with Vemurafenib in melanoma with BRAF V600E mutation
    Chapman PB New Engl J Med 364 2507-2516 [2011]
  • BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas
    Jin SA J Invest Dermatol 133 579-582 [2013]
  • BRAF mutation testing in clinical practice
    Ziai J Expert Rev Mol Diagn 12 127-138 [2012]
  • Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor Vemurafenib in metastatic melanoma
    Halait H Diagn Mol Pathol 21 1-8 [2012]